Who Owns MBX Biosciences Stock?
NASDAQ: MBXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 112.64%
- Institutions (% of float)
- 115.86%
- Held by insiders
- 2.78%
- Institutional holders
- 255
- Institutions 97.2%
- Insiders 2.8%
- Public and other 0.0%
Who owns MBX Biosciences stock?
Institutional investors own about 112.6% of MBX Biosciences's shares, spread across 255 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 2.78% of MBX.
The largest institutional holders are FMR, LLC (14.84%), Frazier Life Sciences Management, L.P. (13.40%) and Wellington Management Group, LLP (10.40%). Together, the top 10 institutions control 77.1% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their MBX positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of MBX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 7.37M | 14.84% | +38.4% |
| Frazier Life Sciences Management, L.P. | 6.65M | 13.40% | 0.0% |
| Wellington Management Group, LLP | 5.16M | 10.40% | +3.8% |
| Paradigm Biocapital Advisors LP | 3.77M | 7.60% | +50.4% |
| NEA Management Company, LLC | 3.61M | 7.28% | 0.0% |
| Blackrock Inc. | 3.47M | 6.99% | +4.5% |
| Orbimed Advisors LLC. | 3.07M | 6.19% | -10.3% |
| NVP Associates, LLC | 2.14M | 4.30% | 0.0% |
| Polar Capital Holdings PLC | 1.60M | 3.23% | -0.3% |
| Vanguard Capital Management LLC | 1.43M | 2.88% | -3.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of MBX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.14M | 2.29% |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 873.49K | 1.76% |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 817.60K | 1.65% |
| iShares Trust-iShares Russell 2000 ETF | 805.56K | 1.62% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 700.00K | 1.41% |
| Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund | 674.70K | 1.36% |
| T. Rowe Price Health Sciences Fund, Inc. | 586.31K | 1.18% |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 416.42K | 0.84% |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 353.15K | 0.71% |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | 345.00K | 0.69% |
Frequently asked questions
Who is the largest shareholder of MBX Biosciences?
FMR, LLC is the largest institutional shareholder of MBX, owning 14.84% of shares outstanding (7.37M shares) as of its latest 13F filing.
What percentage of MBX Biosciences is owned by institutions?
Institutions own about 112.6% of MBX shares and 115.9% of the public float.
How much of MBX Biosciences do insiders own?
Insiders, such as officers and directors, own about 2.78% of MBX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.